CONMED Corporation Announces Amended Start Time for Annual Meeting of Shareholders
CONMED Corporation (NASDAQ: CNMD) today announced an amended start time for its Annual Meeting of Shareholders. The
meeting is now scheduled to begin at 1:30 p.m. ET.
As previously announced, the meeting will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday,
May 22, 2019.
About CONMED Corporation
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery,
gynecology, neurosurgery, thoracic surgery and gastroenterology. For more information, visit
www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions,
factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not
limited to, the risk factors discussed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and
listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all
forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995
and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by
it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in
the forward-looking statements will actually occur or prove to be correct.
CONMED Corporation
Todd Garner
Chief Financial Officer
315-624-3317
ToddGarner@conmed.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190412005056/en/